A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or ...

Growth hormone deficiency (GHD) is a rare disorder characterized by the insufficient production of growth hormone, which is essential for stimulating the growth of bones and other tissues. Children ...

Anne Zimmerman, editor-in-chief of the Columbia University online journal, <a href=" target="_blank">Voices in Bioethics ...

In the world of biopharmaceutical innovation, groundbreaking scientific discoveries often do not directly translate into commercial success. Simply developing a promising therapeutic based on great ...

Even in the best funding environments, raising money for drug discovery is an enormous challenge. It takes about 10 years and upwards of a billion dollars to move a drug candidate from the lab through ...

“I don’t care where you place me, but just make sure it’s terrifying,” was the last input I gave when my company, Novo Nordisk, was determining my job swap for the next year. So when I first learned ...